Equities research analysts expect Cara Therapeutics Inc (NASDAQ:CARA) to post sales of $4.72 million for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for Cara Therapeutics’ earnings, with the lowest sales estimate coming in at $250,000.00 and the highest estimate coming in at $6.80 million. The business is scheduled […]
